The patient been an Enbrel user for over 17 years. Although suffered from psoriasis for many years before that, the patient was offered Enbrel when Rheumatologist suggested as a possible treatment for a psoriatic arthritis which has become a debilitating illness around 2002/2003. On an unknown date, the patient's joints began to swell, and had pain in hands, knees and hips began to affect ability to work. The patient mentioned that, it got to the point that I could hardly walk. The patient said, the use of Enbrel essentially stopped the progression of arthritis and eve reversed some, though not all of topical psoriasis. The patient described that, as the cost of Enbrel started to increase the patient worked out with doctor to change the dosage of Enbrel to determine at which point the patient could stop taking Enbrel. They determined that, the patient could not stop the treatment because after about a month and half, the swelling and pain in joints returned. They established a schedule where the patient could Enbrel every 15 days (which was an off label dosing frequency) or so and even psoriasis returned, joint pain would be controlled. On an unknown date, the patient's new Rheumatologist, prescribed a new format of Enbrel that was Cartridges and changed the dosage to 50 milligram weekly. The patient did not agree with change, but since the patient had been without treatment for over a month, the patient accepted free sample and proceeded to try and get prescription filled. No treatment information was received.